Palvella Therapeutics, Inc. Share Price
NASDAQ: PVLA | Small CapPalvella Therapeutics, Inc. Stock Performance
Palvella Therapeutics, Inc. Share Price Today
As of 30 October 2026, Palvella Therapeutics, Inc.'s share price is $151.32. The stock opened at $154.50, compared to its previous close of $147.64. During today's trading session, Palvella Therapeutics, Inc.'s share price traded between $147.26 and $156.06, with an average price of $151.66. Over the past 52 weeks, the stock has recorded a high of $160.48 and a low of $71.89. In terms of performance, Palvella Therapeutics, Inc.'s share price has risen by 17.94% over the last six months and is up 89.16% on a year-on-year basis.
Palvella Therapeutics, Inc. Share Price Chart
Palvella Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Palvella Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Palvella Therapeutics, Inc.
Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.
Palvella Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $134.99 | $151.41 | +7.94% |
Sep 2026 | $150.16 | $140.28 | -6.57% |
Aug 2026 | $137.99 | $150.14 | +7.82% |
Jul 2026 | $149.11 | $139.25 | -9.06% |
Jun 2026 | $115.47 | $153.13 | +29.64% |
May 2026 | $129.47 | $118.12 | -7.93% |
Apr 2026 | $129.50 | $128.30 | +2.64% |
Mar 2026 | $139.98 | $125.00 | -7.84% |
Feb 2026 | $78.81 | $135.63 | +76.90% |
Jan 2026 | $100.00 | $76.67 | -26.39% |
Dec 2025 | $96.25 | $104.16 | +0.84% |
Nov 2025 | $80.00 | $103.29 | +29.12% |